Evidence map›Paper›PMID 42129118›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Detection of Oxidized Macrophage Migration Inhibitory Factor (oxMIF) in Biological Samples Using Enzyme-Linked Immunosorbent Assay (ELISA).

Gregor Rossmueller, Michael Thiele

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Gregor RossmuellerOncoOne Research & Development GmbH, Karl-Farkas-Gasse 22, A-1030, Vienna, Austria.
Michael ThieleOncoOne Research & Development GmbH, Karl-Farkas-Gasse 22, A-1030, Vienna, Austria. michael.thiele@oncoone.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The enzyme-linked immunosorbent assay (ELISA) is an immunological biochemical assay used to detect and quantify proteins in various sample types including serum, plasma, cell culture medium, cleared bacterial lysate, and buffer. To detect the antigen of interest in these samples, specific antibodies targeting accessible epitopes on antigen's surface are employed. Highly affine antibodies with excellent specificity enable accurate and precise detection and quantification of the protein of interest. This high affinity also facilitates the detection of trace amounts of proteins, which is crucial for analyzing cytokines typically present in much lower concentrations compared to plasma proteins. Plasma levels of oxidized macrophage migration inhibitory factor (oxMIF) can reach 150 ng/mL or higher, but concentrations below 20 ng/mL are more common. In addition, differentiating between the pathological isoform oxMIF and MIF is necessary. Here, we describe a method to detect oxMIF and MIF in various sample matrices of biological origin using the sandwich ELISA method.

Indexed as

Intramolecular OxidoreductasesMacrophage Migration-Inhibitory FactorsAnimalsEnzyme-Linked Immunosorbent AssayHumansOxidation-ReductionIntramolecular OxidoreductasesMacrophage Migration-Inhibitory FactorsAntibodiesBiomarkerCell culture supernatantEnzyme-linked immunosorbent assayOxMIFPlasma

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.